Grigorian R - Search Results

1

Corrigendum to "The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema" [Am J Ophthalmol 2023;248;16-23].

Merrill PT, Holekamp N, Roth D, Kasper J, Grigorian R; PALADIN Study Group. Merrill PT, et al. Among authors: grigorian r. Am J Ophthalmol. 2023 Aug;252:336. doi: 10.1016/j.ajo.2023.05.001. Epub 2023 May 22. Am J Ophthalmol. 2023. PMID: 37225642 Free article. No abstract available.

2

Penetrating trauma associated with findings of multiple evanescent white dot syndrome in the second eye: coincidence or an atypical case of sympathetic ophthalmia?

Landolfi M, Bhagat N, Langer P, Rescigno R, Mirani N, Gass JD, Grigorian RA, Zarbin MA. Landolfi M, et al. Among authors: grigorian ra. Retina. 2004 Aug;24(4):637-45. doi: 10.1097/00006982-200408000-00029. Retina. 2004. PMID: 15300097

3

Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.

Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.

4

The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema.

Merrill PT, Holekamp N, Roth D, Kasper J, Grigorian R; PALADIN Study Group. Merrill PT, et al. Among authors: grigorian r. Am J Ophthalmol. 2023 Apr;248:16-23. doi: 10.1016/j.ajo.2022.09.017. Epub 2022 Oct 9. Am J Ophthalmol. 2023. PMID: 36223849 Free article.

5

Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.

Hutton DW, Glassman AR, Liu D, Sun JK; DRCR Retina Network. Hutton DW, et al. JAMA Ophthalmol. 2023 Mar 1;141(3):268-274. doi: 10.1001/jamaophthalmol.2022.6142. JAMA Ophthalmol. 2023. PMID: 36729431 Free PMC article. Clinical Trial.

6

The 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: Intraocular Pressure-Related Effects over 36 Months.

Roth DB, Eichenbaum D, Malik D, Radcliffe NM, Cutino A, Small KW; PALADIN Study Group. Roth DB, et al. Ophthalmol Retina. 2024 Jan;8(1):49-54. doi: 10.1016/j.oret.2023.08.004. Epub 2023 Aug 14. Ophthalmol Retina. 2024. PMID: 37586482 Free article.

7

Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40.

Jhaveri CD, Liu D, Maguire MG, Glassman AR, Grigorian RA, Jampol LM, Kingsley RM, MacCumber MW, Martin DF, Maturi RK, Velez G, Sun JK; DRCR Retina Network. Jhaveri CD, et al. Among authors: grigorian ra. Ophthalmology. 2024 Feb 8:S0161-6420(24)00098-8. doi: 10.1016/j.ophtha.2024.01.037. Online ahead of print. Ophthalmology. 2024. PMID: 38336282

8

Pars plana vitrectomy for refractory diabetic macular edema.

Grigorian R, Bhagat N, Lanzetta P, Tutela A, Zarbin M. Grigorian R, et al. Semin Ophthalmol. 2003 Sep;18(3):116-20. doi: 10.1076/soph.18.3.116.29813. Semin Ophthalmol. 2003. PMID: 15513471 Review.

9

Diabetic macular edema: pathogenesis and treatment.

Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Bhagat N, et al. Surv Ophthalmol. 2009 Jan-Feb;54(1):1-32. doi: 10.1016/j.survophthal.2008.10.001. Surv Ophthalmol. 2009. PMID: 19171208 Review.

10

Evolution of sarcoid granulomas of the retina.

Frohman L, Grigorian R, Slamovits T. Frohman L, et al. Among authors: grigorian r. Am J Ophthalmol. 2001 May;131(5):661-2. doi: 10.1016/s0002-9394(00)00880-1. Am J Ophthalmol. 2001. PMID: 11336948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page